Biotechnology Press Release
|05/18/2020 - 08:18||
Five URI students awarded prestigious NSF graduate research fellowships
KINGSTON, R.I. ? May 18, 2020 ? Five University of Rhode Island students have been recognized by the National Science Foundation as Graduate Research Fellows, a distinction that includes funding to cover three years of their graduate education plus an annual $34,000 stipend.
|University of R...|
|05/18/2020 - 05:21||
Permission to Be Wild: Scientists Reflect on the Vilcek Prizes
The Vilcek Foundation?s prizes program advances the foundation?s mission through direct support to foreign-born professionals in biomedical science and in the arts, in acknowledgment of the careers of the foundation?s cofounders, Jan and Marica Vilcek.
|05/18/2020 - 05:00||
Athersys Announces Upcoming Presentations at the International Society of Cell and Gene Therapy Virtual Conference
Company will participate in three events at the largest global translation-focused cell and gene therapy meeting.
|05/18/2020 - 03:29||
How fungi are becoming the future
This policy paper , recently published by the pan-European think tank EUROFUNG headed by Professor Dr.-Ing. Vera Meyer (TU Berlin), summarizes the discussions taking place place between leading European and American researchers and global businesses.
|05/17/2020 - 23:42||
Statement on Newly Finalized Federal Regulations on GMOs
Washington, D.C. ?Center for Food Safety (CFS) condemns the U.S. Department of Agriculture's (USDA) revised regulations governing genetically engineered (GE) organisms (commonly referred to as GMOs). USDA released an unofficial version of the new regulations on its website yesterday, announcing that the regulations will be officially published in the Federal Register on Monday, May 18, 2020.
|Center for Food...|
|05/17/2020 - 23:20||
Newly Finalized Federal Regulations on GMOs Are a "Free for All" for Chemical Corporations
The finalized regulations differ little from USDA's draft regulations proposed last summer. Under the new regime, many GMOs that are currently regulated will no longer be subject to agency oversight, with developers (e.g.
|Center for Food...|
|05/17/2020 - 20:39||
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
World-class platform will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patients
|05/15/2020 - 18:14||
Trump Administrations USDA Limits Oversight of Genetically Engineered and Gene Edited Crops
Washington, D.C. ? A majority of genetically engineered and gene edited plants now will escape any oversight on the part of the U.S. Department of Agriculture under revised regulations issued today by the agency
|05/15/2020 - 07:15||
Lupin Extends Jan Kovid Helpline for Bhopal and Indore Citizens
Mumbai, India, May 15, 2020: Pharma major Lupin Limited (Lupin) today announced the extension of the ?Jan Kovid? Helpline ( 1800-572-6130) for the residents of Bhopal and Indore.
|05/15/2020 - 07:13||
Sheffield scientists sequence over 1,000 Covid-19 genomes to aid pandemic response
Scientists at the University of Sheffield and clinicians from Sheffield Teaching Hospitals NHS Foundation Trust have reached a major milestone of their work as part of a national effort to map the spread of coronavirus The teams have now uploaded a staggering 1,000 genome sequences to the Covid-19 Genomics UK (COG-UK) Consortium, helping researchers around the world The work has been backed by the UK government as part of a £20 million investment in a consortium helping the national response to the pandemic The genetic code could arm public health agencies and clinicians with cutting edg
|05/15/2020 - 06:42||
Transgene and NEC demonstrate high accuracy of AI-based neoantigen prediction for the design of individualized cancer vaccine TG4050
TG4050 is being evaluated in two Phase 1 clinical trials. It combines Transgene’s proprietary myvac® platform with NEC’s cutting-edge Artificial Intelligence (AI) capabilities to select patient-specific neoantigens Data confirm that the prediction algorithm successfully identifies immunogenic cancer mutations, even among a large set of candidate mutations Data will be presented at upcoming Virtual AACR 2020 Session II
|05/15/2020 - 06:26||
Exploring diseases' sex differences, new uses for old drugs in treating COVID-19, a new perspective on brain tumor cells, and more
Welcome to the May 15, 2020 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators.
|05/15/2020 - 05:27||
All COVIDCon Videos Available Now
While governments around the world struggle with COVID-19, dissidents and civil society leaders continue their fight for freedom and democracy under increasingly difficult conditions .
|Human Rights Fo...|
|05/15/2020 - 05:23||
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
T he governing Board of the California Institute for Regenerative Medicine (CIRM) today approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19.
|05/14/2020 - 23:06||
GlycoMimetics to Present New Preclinical Data Highlighting Biomarkers and Potential Expanded Pipeline Opportunities at Virtual AACR Annual Meeting 2020
During the June session, GlycoMimetics will present preclinical data that further support the potential of the Company’s compounds to be used in the treatment of acute myeloid leukemia (AML) as well as in the setting of stem cell transplantation. Additionally, new information will be presented on the ability of transcriptome profiling to identify those tumor types most likely to benefit from targeted E-selectin inhibition, a key mechanism of GlycoMimetics drug candidates, supporting their potential uses in a biomarker-driven approach.
|05/14/2020 - 23:04||
STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies
As recently announced, Sorrento aims to generate an antibody cocktail product that would act as a "protective shield" against SARS-CoV-2 coronavirus infection and remain effective even if virus mutations render a single antibody therapy less effective over time.
|05/14/2020 - 14:22||
Athersys to Present at the Bank of America Merrill Lynch Virtual Healthcare Conference on May 14
CLEVELAND--( )-- Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the Bank of America Merrill Lynch 2020 Virtual Healthcare Conference to investors and analysts. The presentation is scheduled for Thursday, May 14, 2020 at 8:20 a.m.
|05/14/2020 - 14:12||
USDA SECURE Rule Paves Way for Agricultural Innovation
The Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient (SECURE) rule will bring USDA’s plant biotechnology regulations into the 21st century by removing duplicative and antiquated processes in order to facilitate the development and availability of these technologies through a transparent, consistent, science-based, and risk-proportionate regulatory system.
|05/14/2020 - 11:53||
New research into stem cell mutations could improve regenerative medicine
New research from the University of Sheffield into stem cells could help make regenerative medicine safer Regenerative medicine involves using pluripotent stem cells to repair damaged or diseased tissues in the body The new research has suggested ways to reduce the likelihood of mutations occurring in these cells when cultured.
|05/14/2020 - 10:06||
New faculty chair to enhance leadership in plant biology
UNIVERSITY PARK, Pa. — Alumnus Harold L. Kohn and his wife Carol K. Kohn have pledged $2 million from the Kohn Charitable Trust to create the Louis and Hedwig Sternberg Chair in Plant Biology in the Eberly College of Science. The chair, which honors Harold’s grandparents, is designed to enhance Penn State’s position of leadership in plant biology.
|05/14/2020 - 10:02||
Adventures in Organ LR Asymmetry: Role of Pitx2 in Gut Lymphatic Development and Lipid Transport Function
Other Tri-Institutional Events Natasza Kurpios, Ph.D., Associate Professor, Department of Molecular Medicine, Cornell University College of Veterinary Medicine.
|05/14/2020 - 09:23||
Setting up a pharmaceutical manufacturing supply chain is a complex and lengthy process
Did you know that biopharmaceutical manufacturers must begin setting up the manufacturing supply chain for a medicine years before that medicine is even approved for use by patients? That?s a fact that is frequently overlooked by policymakers who are proposing drastic, mandated changes to pharmaceutical supply chains. Changes made to any supply chain require careful consideration and planning, as well as substantial engagement with FDA to obtain regulatory review and approval.
|05/14/2020 - 07:24||
Repurposed drug helps obese mice lose weight, improve metabolic function
Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study.
|05/14/2020 - 06:51||
World leaders unite in call for a peoples vaccine against COVID-19
More than 140 world leaders and experts, including the President of South Africa and Chair of the African Union, Cyril Ramaphosa, the Prime Minister of Pakistan, Imran Khan, the President of the Republic of Senegal, Macky Sall and the President of the Republic of Ghana, Nana Addo Dankwa Akufo-Addo have signed an open letter calling on all governments to unite behind a people’s vaccine against COVID-19. The call was made just days before health ministers meet virtually for the World Health Assembly on 18 May.
|05/14/2020 - 01:56||
Trump Administration Withdraws Oversight of Gene Edited Crops, Removing Critical Safeguards
Multiple environmental groups, consumer organizations, biotech crop developers and food industry stakeholders have expressed concerns with provisions that allow crop developers to self-determine whether their products are subject to regulation and release products into the market without any record.